SAFETY AND FEASIBILITY OF AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STEM CELL TREATMENT IN REFRACTORY CROHN'S DISEASE PATIENTS

(1) Gastroenterology and Hepatology

(2) Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands



This item was part of the New approaches to IBD therapy: Stem cells and other agents session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A10